State-of-the-art 3T MRI and cutting-edge molecular imaging are fully integrated as one. Only Siemens makes the simultaneous acquisition of whole-body MR and PET possible. Molecular MR supports our ...

Novartis noted that a dedicated diagnostics owner would better support molecular imaging's growth prospects, leading to this ...

Siemens is the largest global manufacturer of MR, CT, X-ray, and molecular imaging. In the advanced therapies segment, the firm holds a top market position in hybrid operating rooms and ...

Siemens Healthineers (SEMHF) is a company that I have written about a few times in the past. See why I rate the stock a buy ...

A version of this advanced scanner, produced by Siemens, was approved by the U.S. Food and Drug Administration for clinical ...

Stifel Nicolaus analyst Dylan Van Haaften has maintained their bullish stance on SEMHF stock, giving a Buy rating yesterday. Dylan Van ...

Siemens’ Molecular Imaging research facility is dedicated to the development of molecular imaging biomarkers for identifying debilitating diseases at their earliest stages. The PDC allocates funds to ...

The firm reported that its adjusted diagnostics revenues rose less than 1 percent, excluding the COVID-19 rapid antigen testing business that the firm exited last year.

It operates through the following business segments: Imaging ... care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the ...

IMDX Monkeypox Detection RT-PCR Assay by Siemens Healthineers has received ... and Magnetic Resonance Imaging (MRI) devices. The new facility is approved under the Radiology and Imaging Medical ...